Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
LY-518674
(2)
Small molecule
Peroxisome proliferator-activated receptor alpha agonist
Unknown
Investigational
Unknown
LY-518674
×
Maximum Phase:
2
First Approval:
None
UNII:
U8I57RC739
Molecule Type:
Small molecule
Molecular Formula:
C23H27N3O4
Molecular Weight:
409.49
AlogP:
3.76
PSA:
97.47
HBD:
2.0
HBA:
#RotB:
9.0
Source:
MBX-2044
(2)
Small molecule
Peroxisome proliferator-activated receptor gamma modulator
Unknown
Investigational
Unknown
MBX-2044
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASPACYTARABINE
(2)
Small molecule
DNA disrupting agent
Unknown
Investigational
Unknown
ASPACYTARABINE
×
Maximum Phase:
2
First Approval:
None
UNII:
JL7V54Z2BR
Molecule Type:
Small molecule
Molecular Formula:
C13H18N4O8
Molecular Weight:
358.31
AlogP:
-3.4
PSA:
197.23
HBD:
6.0
HBA:
#RotB:
6.0
Source:
PALOSURAN
(2)
Small molecule
Urotensin II receptor antagonist
Unknown
Investigational
Unknown
PALOSURAN
×
Maximum Phase:
2
First Approval:
None
UNII:
ULD9ZKE457
Molecule Type:
Small molecule
Molecular Formula:
C25H30N4O2
Molecular Weight:
418.54
AlogP:
3.73
PSA:
77.49
HBD:
3.0
HBA:
#RotB:
6.0
Source:
IZORLISIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
IZORLISIB
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TOMIVOSERTIB
(2)
Small molecule
MAP kinase-interacting serine/threonine-protein kinase 1/2 inhibitor
Unknown
Investigational
Unknown
TOMIVOSERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
U2H19X4WBV
Molecule Type:
Small molecule
Molecular Formula:
C17H20N6O2
Molecular Weight:
340.39
AlogP:
1.63
PSA:
114.93
HBD:
3.0
HBA:
#RotB:
2.0
Source:
SOLABEGRON
(2)
Small molecule
Beta-3 adrenergic receptor agonist
Unknown
Investigational
Unknown
SOLABEGRON
×
Maximum Phase:
2
First Approval:
None
UNII:
55P6YH9O6N
Molecule Type:
Small molecule
Molecular Formula:
C23H23ClN2O3
Molecular Weight:
410.9
AlogP:
4.44
PSA:
81.59
HBD:
4.0
HBA:
#RotB:
9.0
Source:
LXH254
(2)
Small molecule
B-raf/RAF proto-oncogene serine/threonine-protein kinase inhibitor
Unknown
Investigational
Unknown
LXH254
×
Maximum Phase:
2
First Approval:
None
UNII:
15JL80DG6H
Molecule Type:
Small molecule
Molecular Formula:
C25H25F3N4O4
Molecular Weight:
502.49
AlogP:
3.93
PSA:
96.81
HBD:
2.0
HBA:
#RotB:
7.0
Source:
BFPET
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
BFPET
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C24H19FP+
Molecular Weight:
357.39
AlogP:
4.45
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
4.0
Source:
(-)-PROPANOLOL
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
(-)-PROPANOLOL
×
Maximum Phase:
2
First Approval:
None
UNII:
74MLR03FLC
Molecule Type:
Small molecule
Molecular Formula:
C16H21NO2
Molecular Weight:
259.35
AlogP:
2.58
PSA:
41.49
HBD:
2.0
HBA:
#RotB:
6.0
Source:
BEMCENTINIB
(2)
Small molecule
Tyrosine-protein kinase receptor UFO inhibitor
Unknown
Investigational
Unknown
BEMCENTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
0ICW2LX8AS
Molecule Type:
Small molecule
Molecular Formula:
C30H34N8
Molecular Weight:
506.66
AlogP:
4.88
PSA:
97.78
HBD:
2.0
HBA:
#RotB:
4.0
Source:
NM-404 I-124
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
NM-404 I-124
×
Maximum Phase:
2
First Approval:
None
UNII:
08W354EC17
Molecule Type:
Small molecule
Molecular Formula:
C29H53INO4P
Molecular Weight:
634.63
AlogP:
8.28
PSA:
58.59
HBD:
0.0
HBA:
#RotB:
24.0
Source:
FLUBROBENGUANE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
FLUBROBENGUANE
×
Maximum Phase:
2
First Approval:
None
UNII:
XCG95AYX3B
Molecule Type:
Small molecule
Molecular Formula:
C11H15BrFN3O
Molecular Weight:
304.16
AlogP:
2.17
PSA:
71.13
HBD:
3.0
HBA:
#RotB:
6.0
Source:
DEXELVUCITABINE
(2)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
Unknown
Investigational
Unknown
DEXELVUCITABINE
×
Maximum Phase:
2
First Approval:
None
UNII:
KU8SPJ271W
Molecule Type:
Small molecule
Molecular Formula:
C9H10FN3O3
Molecular Weight:
227.19
AlogP:
-0.59
PSA:
90.37
HBD:
2.0
HBA:
#RotB:
2.0
Source:
OMAVELOXOLONE
(2)
Small molecule
Unknown
Unknown
Approved
Unknown
OMAVELOXOLONE
×
Maximum Phase:
2
First Approval:
None
UNII:
G69Z98951Q
Molecule Type:
Small molecule
Molecular Formula:
C33H44F2N2O3
Molecular Weight:
554.72
AlogP:
6.73
PSA:
87.03
HBD:
1.0
HBA:
#RotB:
2.0
Source:
STX107
(2)
Small molecule
Metabotropic glutamate receptor 5 negative allosteric modulator
Unknown
Investigational
Unknown
STX107
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SPEBRUTINIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
SPEBRUTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
DRU6NG543J
Molecule Type:
Small molecule
Molecular Formula:
C22H22FN5O3
Molecular Weight:
423.45
AlogP:
4.25
PSA:
97.4
HBD:
3.0
HBA:
#RotB:
10.0
Source:
MK-0533
(2)
Small molecule
Peroxisome proliferator-activated receptor gamma modulator
Unknown
Investigational
Unknown
MK-0533
×
Maximum Phase:
2
First Approval:
None
UNII:
J17152066B
Molecule Type:
Small molecule
Molecular Formula:
C28H24F3NO6
Molecular Weight:
527.5
AlogP:
6.32
PSA:
86.99
HBD:
1.0
HBA:
#RotB:
9.0
Source:
AMPELOPSIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
AMPELOPSIN
×
Maximum Phase:
2
First Approval:
None
UNII:
KD8QND6427
Molecule Type:
Small molecule
Molecular Formula:
C15H12O8
Molecular Weight:
320.25
AlogP:
0.89
PSA:
147.68
HBD:
6.0
HBA:
#RotB:
1.0
Source:
SCH-486757
(2)
Small molecule
Nociceptin receptor agonist
Unknown
Investigational
Unknown
SCH-486757
×
Maximum Phase:
2
First Approval:
None
UNII:
2HV668N62T
Molecule Type:
Small molecule
Molecular Formula:
C24H23Cl2N3O
Molecular Weight:
440.37
AlogP:
5.39
PSA:
49.25
HBD:
1.0
HBA:
#RotB:
4.0
Source:
EZUTROMID
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
EZUTROMID
×
Maximum Phase:
2
First Approval:
None
UNII:
645R07LF0D
Molecule Type:
Small molecule
Molecular Formula:
C19H15NO3S
Molecular Weight:
337.4
AlogP:
4.44
PSA:
60.17
HBD:
0.0
HBA:
#RotB:
3.0
Source:
AVAROFLOXACIN
(2)
Small molecule
Bacterial DNA gyrase inhibitor
Unknown
Investigational
Unknown
AVAROFLOXACIN
×
Maximum Phase:
2
First Approval:
None
UNII:
070SV15RJA
Molecule Type:
Small molecule
Molecular Formula:
C21H23F2N3O4
Molecular Weight:
419.43
AlogP:
2.96
PSA:
97.79
HBD:
2.0
HBA:
#RotB:
5.0
Source:
DEUTERIUM OXIDE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
DEUTERIUM OXIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
J65BV539M3
Molecule Type:
Small molecule
Molecular Formula:
H2O
Molecular Weight:
20.03
AlogP:
-0.82
PSA:
31.5
HBD:
0.0
HBA:
#RotB:
0.0
Source:
ROVAFOVIR ETALAFENAMIDE
(2)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
Unknown
Investigational
Unknown
ROVAFOVIR ETALAFENAMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
U8S0IC8DY7
Molecule Type:
Small molecule
Molecular Formula:
C21H24FN6O6P
Molecular Weight:
506.43
AlogP:
2.9
PSA:
152.71
HBD:
2.0
HBA:
#RotB:
10.0
Source:
NIDUFEXOR
(2)
Small molecule
Bile acid receptor FXR agonist
Unknown
Investigational
Unknown
NIDUFEXOR
×
Maximum Phase:
2
First Approval:
None
UNII:
CJ1PL0TE6J
Molecule Type:
Small molecule
Molecular Formula:
C27H22ClN3O4
Molecular Weight:
487.94
AlogP:
5.17
PSA:
84.66
HBD:
1.0
HBA:
#RotB:
6.0
Source:
NAPROXEN ETEMESIL
(2)
Small molecule
Cyclooxygenase inhibitor
Unknown
Investigational
Unknown
NAPROXEN ETEMESIL
×
Maximum Phase:
2
First Approval:
None
UNII:
214269U36R
Molecule Type:
Small molecule
Molecular Formula:
C17H20O5S
Molecular Weight:
336.41
AlogP:
2.54
PSA:
69.67
HBD:
0.0
HBA:
#RotB:
6.0
Source:
RESMINOSTAT
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
RESMINOSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
1578EUB98L
Molecule Type:
Small molecule
Molecular Formula:
C16H19N3O4S
Molecular Weight:
349.41
AlogP:
1.31
PSA:
91.64
HBD:
2.0
HBA:
#RotB:
6.0
Source:
SB-705498
(2)
Small molecule
Vanilloid receptor antagonist
Unknown
Investigational
Unknown
SB-705498
×
Maximum Phase:
2
First Approval:
None
UNII:
T74V9O0Y2W
Molecule Type:
Small molecule
Molecular Formula:
C17H16BrF3N4O
Molecular Weight:
429.24
AlogP:
4.26
PSA:
57.26
HBD:
2.0
HBA:
#RotB:
3.0
Source:
ENCALERET SULFATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ENCALERET SULFATE
×
Maximum Phase:
2
First Approval:
None
UNII:
7CKZ1Y8K70
Molecule Type:
Small molecule
Molecular Formula:
C58H70Cl2F2N2O13S
Molecular Weight:
1144.17
AlogP:
6.2
PSA:
78.79
HBD:
3.0
HBA:
#RotB:
11.0
Source:
OSI-632
(2)
Small molecule
Vascular endothelial growth factor receptor 2 inhibitor
Unknown
Investigational
Unknown
OSI-632
×
Maximum Phase:
2
First Approval:
None
UNII:
W1B375O5M2
Molecule Type:
Small molecule
Molecular Formula:
C20H24BrF2N5O3S
Molecular Weight:
532.41
AlogP:
3.86
PSA:
109.58
HBD:
3.0
HBA:
#RotB:
10.0
Source:
KD7040
(2)
Small molecule
Nitric oxide synthase, inducible inhibitor
Unknown
Investigational
Unknown
KD7040
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C17H20N6O2S
Molecular Weight:
372.45
AlogP:
2.07
PSA:
77.33
HBD:
1.0
HBA:
#RotB:
8.0
Source:
BUCINDOLOL
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
BUCINDOLOL
×
Maximum Phase:
2
First Approval:
None
UNII:
E9UO06K7CE
Molecule Type:
Small molecule
Molecular Formula:
C22H25N3O2
Molecular Weight:
363.46
AlogP:
3.39
PSA:
81.07
HBD:
3.0
HBA:
#RotB:
8.0
Source:
NIVOCASAN
(2)
Small molecule
Caspase-1 inhibitor
Unknown
Investigational
Unknown
NIVOCASAN
×
Maximum Phase:
2
First Approval:
None
UNII:
9554OW6MVU
Molecule Type:
Small molecule
Molecular Formula:
C21H22FN3O5
Molecular Weight:
415.42
AlogP:
1.84
PSA:
110.11
HBD:
2.0
HBA:
#RotB:
5.0
Source:
RICOLINOSTAT
(2)
Small molecule
Histone deacetylase 6 inhibitor
Unknown
Investigational
Unknown
RICOLINOSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
WKT909C62B
Molecule Type:
Small molecule
Molecular Formula:
C24H27N5O3
Molecular Weight:
433.51
AlogP:
4.13
PSA:
107.45
HBD:
3.0
HBA:
#RotB:
11.0
Source:
BENTAMAPIMOD
(2)
Small molecule
c-Jun N-terminal kinase, JNK inhibitor
Unknown
Investigational
Unknown
BENTAMAPIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
TT3L4B4U0N
Molecule Type:
Small molecule
Molecular Formula:
C25H23N5O2S
Molecular Weight:
457.56
AlogP:
4.15
PSA:
84.16
HBD:
0.0
HBA:
#RotB:
7.0
Source:
ICOSABUTATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ICOSABUTATE
×
Maximum Phase:
2
First Approval:
None
UNII:
562599X5JL
Molecule Type:
Small molecule
Molecular Formula:
C24H38O3
Molecular Weight:
374.57
AlogP:
6.79
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
17.0
Source:
1
2
…
157
158
159
160
161
162
163
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA